The Claim

Higher plasma levels of myeloperoxidase (MPO) are associated with increased odds of mild cognitive impairment (MCI) in older adults aged 70–80 at high risk of mobility disability, with individuals in the highest quartile of MPO having 1.79 times the odds of MCI at baseline and 1.92 times the odds of incident MCI or dementia over 24 months compared to those in the lowest quartile.

Source: Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
83score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Older adults aged 70–80 at high risk of mobility disability with higher levels of myeloperoxidase in their blood have a higher likelihood of developing mild cognitive impairment or dementia over two years compared to those with lower levels.

See the scientific wording

Higher plasma levels of myeloperoxidase (MPO) are associated with increased odds of mild cognitive impairment (MCI) in older adults aged 70–80 at high risk of mobility disability, with those in the highest quartile having nearly double the odds (OR = 1.79, 95% CI: 1.02–3.22) compared to the lowest quartile at baseline, and a similar association observed for incident MCI or dementia over 24 months (OR = 1.92, 95% CI: 1.16–3.25), suggesting MPO may serve as a circulating biomarker linked to cognitive decline in this population.

Why this might work

White blood cells release a chemical called myeloperoxidase into the blood, which reacts with other molecules to create highly damaging substances that attack brain cells. These substances break down fats in brain cell membranes, trigger inflammation inside the brain, and damage the barrier that protects the brain from harmful substances. Over time, this damage kills brain connections and neurons, leading to memory problems and cognitive decline.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study

    Older adults with more myeloperoxidase in their blood were much more likely to develop memory problems over two years, suggesting this protein could be a warning sign for brain health issues.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.